ave5026 dose for the treatment of venous thromboembolism in patients with severe renal impairment
- 专利权人:
- Sanofi
- 发明人:
- Catherine Dubruc,Pierre-François Clot
- 申请号：
- BRPI1009322
- 公开号：
- BRPI1009322A2
- 申请日:
- 2010.03.18
- 申请国别(地区):
- BR
- 年份:
- 2019
- 代理人:
- 摘要：
- The invention relates to a dose of 10 mg of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- DOSE AVE5026 FOR THE TREATMENT OF VENE THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL FAILURE
- DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
- A DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
- Preventive And/Or Therapeutic Agent For Thromboembolism In Thromboembolism Patient With Severe Renal Impairment
- PREVENTIVE AND/OR THERAPEUTIC AGENT FOR THROMBOEMBOLISM IN THROMBOEMBOLISM PATIENT WITH SEVERE RENAL IMPAIRMENT
